AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vilipta M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Relics Pharmaceutical Private Limited

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vilipta M 500mg/50mg Tablet

Combiflor 500mg/50mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events such as heart attacks and strokes. Combiflor 500mg/50mg may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved when coupled with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering current health status, blood glucose readings, and other concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under medical supervision. Maintaining controlled blood sugar levels aids in preventing long-term complications. Adherence to the physician's prescribed diet and exercise plan is crucial for successful diabetes management; lifestyle choices significantly impact disease control. Commonly reported side effects include nausea, vomiting, diarrhea, indigestion, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; patients should be aware of its symptoms and management. This medication isn't suitable for all patients. Prior to commencing treatment, individuals with pre-existing kidney, liver, or heart conditions, pancreatic disorders, or significant alcohol consumption should inform their physician. Pregnant or lactating women require medical consultation before use. Potential drug interactions necessitate disclosing all current medications to ensure treatment safety. Alcohol consumption should be minimized due to its potential to lower blood glucose. Regular monitoring of renal function and blood glucose levels will be conducted by your doctor throughout the treatment period.

Primary Ingredients of Vilipta M 500mg/50mg Tablet

No information provided. Please provide the text you wish me to rephrase.

Uses of Vilipta M 500mg/50mg Tablet

Managing type 2 diabetes

Major Benefits of Vilipta M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It is recommended to take Vilipta M 500mg/50mg tablets with food.

Common Side effects of Vilipta M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vilipta M 500mg/50mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Vilipta M 500mg/50mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Vilipta M 500mg/50mg Tablet works:

The tablet Vilipta M, containing 500mg/50mg of a dual antidiabetic formulation, combines two distinct medications.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Vilipta M 500mg/50mg tablets is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Vilipta M 500mg/50mg tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers before prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Vilipta M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Vilipta M 500mg/50mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Use of Vilipta M 500mg/50mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Vilipta M 500mg/50mg Tablet :

Should you forget a Vilipta M 500mg/50mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Vilipta M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vilipta M 500mg/50mg Tablet

Vilipta M 500mg/50mg Tablets rarely cause hypoglycemia by themselves. However, low blood sugar can result from inadequate calorie intake while using this medication. Symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness may occur, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise is undertaken, or other antidiabetic medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vilipta M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Vilipta M 500mg/50mg Tablet is contraindicated in patients with allergies to its components or excipients, and should not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Vilipta M 500mg/50mg tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vilipta M 500mg/50mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excess blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Vilipta M 500mg/50mg Tablets and seek immediate medical attention.
Prolonged use of Vilipta M 500mg/50mg Tablet can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vilipta M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with proper usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (if also taking insulin or sulphonylurea) may occur. Report any persistent issues to your physician.
Vilipta M 500mg/50mg Tabl...
93
MRP 108
13% off